Results for tag: "D1 Agonist"

The D1 Agonist market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. D1 Agonists are a type of dopamine receptor agonist, which are drugs that activate dopamine receptors in the brain. These drugs are used to treat a variety of conditions, including Parkinson's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). D1 Agonists are also used to treat drug addiction and to reduce the risk of relapse. The D1 Agonist market is highly competitive, with a number of companies offering products. Some of the major players in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more